LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL)
Clinical trial NCT00082225 · TERMINATED
Trial details
- NCT number
- NCT00082225
- Sponsor
- Baylor College of Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2006-02-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.